76 related articles for article (PubMed ID: 1330001)
21. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
22. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.
Karasuyama H; Melchers F
Eur J Immunol; 1988 Jan; 18(1):97-104. PubMed ID: 2831066
[TBL] [Abstract][Full Text] [Related]
23. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines.
Bussolino F; De Rossi M; Sica A; Colotta F; Wang JM; Bocchietto E; Padura IM; Bosia A; DeJana E; Mantovani A
J Immunol; 1991 Oct; 147(7):2122-9. PubMed ID: 1918946
[TBL] [Abstract][Full Text] [Related]
24. Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line.
Dornand J; Bouaboula M; d'Angeac AD; Favero J; Shire D; Casellas P
J Cell Physiol; 1992 Apr; 151(1):71-80. PubMed ID: 1560050
[TBL] [Abstract][Full Text] [Related]
25. Segregation properties of bovine papillomaviral plasmid DNA.
Stewart AC; Jareborg N; Simonsson M; Alderborn A; Burnett S
J Mol Biol; 1994 Feb; 236(2):480-90. PubMed ID: 8107134
[TBL] [Abstract][Full Text] [Related]
26. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
27. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine.
Su ZZ; Shen R; O'Brian CA; Fisher PB
Oncogene; 1994 Apr; 9(4):1123-32. PubMed ID: 7510863
[TBL] [Abstract][Full Text] [Related]
28. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
[TBL] [Abstract][Full Text] [Related]
29. A methylation profile of in vitro immortalized human cell lines.
Liu L; Zhang J; Bates S; Li JJ; Peehl DM; Rhim JS; Pfeifer GP
Int J Oncol; 2005 Jan; 26(1):275-85. PubMed ID: 15586250
[TBL] [Abstract][Full Text] [Related]
30. Tumorigenicity of revertant from an SV40-transformed line.
Steinberg BM; Rifkin D; Shin S; Boone C; Pollack R
J Supramol Struct; 1979; 11(4):539-46. PubMed ID: 232523
[TBL] [Abstract][Full Text] [Related]
31. Expression of a retinoic Acid-inducible mitochondrial nd5 gene is regulated by cell-density in bovine papillomavirus DNA-transformed mouse c127 cells but not in revertant cells.
Li G; Liu Y; Tsang S
Int J Oncol; 1994 Aug; 5(2):301-7. PubMed ID: 21559589
[TBL] [Abstract][Full Text] [Related]
32. Bovine papillomavirus type 1-transformed primary mouse fibroblasts show no correlation between tumorigenicity and viral gene expression, but c-myc gene expression is elevated in tumorigenic cell lines.
Agrawal R; Pelkonen J; Mäntyjärvi RA
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1527-32. PubMed ID: 1318945
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
Mäntyjärvi R; Sarkkinen H; Parkkinen S; Laatikainen A; Ryhänen A; Syrjänen K
Intervirology; 1988; 29(6):311-9. PubMed ID: 2852654
[TBL] [Abstract][Full Text] [Related]
34. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells.
Himelstein BP; Canete-Soler R; Bernhard EJ; Muschel RJ
J Cell Sci; 1994 Feb; 107 ( Pt 2)():477-86. PubMed ID: 8207074
[TBL] [Abstract][Full Text] [Related]
35. Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.
Laatikainen A; Sarkkinen H; Syrjänen K; Mäntyjärvi R
APMIS; 1990 Oct; 98(10):909-15. PubMed ID: 2173935
[TBL] [Abstract][Full Text] [Related]
36. Tumour-associated antigens in primary mouse fibroblasts induced by transformation with bovine papillomavirus type 1.
Mäntyjärvi RA; Sarkkinen H; Karajalainen H; Parkkinen S; Ryhänen A; Syrjänen K; Jägerroos H; Nurmi T
Exp Pathol; 1988; 35(1):25-33. PubMed ID: 2852603
[TBL] [Abstract][Full Text] [Related]
37. Retinoic Acid induces loss of viral-DNA, phenotypic reversion and transformation-resistance of bovine papillomavirus type-1 DNA-transformed cells.
Li G; Tsang S; Lam P; Stich H
Int J Oncol; 1993 Aug; 3(2):319-24. PubMed ID: 21573367
[TBL] [Abstract][Full Text] [Related]
38. Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.
Laatikainen A; Karjalainen H; Jägerroos H; Sarkkinen H; Mäntyjärvi R
Cancer Immunol Immunother; 1990; 31(3):164-8. PubMed ID: 2159847
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells.
Morgan D; Pecoraro G; Rosenberg I; Defendi V
J Virol; 1990 Mar; 64(3):969-76. PubMed ID: 2154622
[TBL] [Abstract][Full Text] [Related]
40. The in vivo enhancement of IL-1alpha receptor expression on polyoma virus transformed tumor derived cells.
Arons E; Zusman T; Ran M
Int J Oncol; 1998 Jun; 12(6):1379-83. PubMed ID: 9592203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
